| 5.7 |
17.0 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 3.5 |
10.6 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 3.3 |
13.0 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 2.6 |
2.6 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 2.4 |
2.4 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 2.3 |
6.9 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 2.3 |
6.8 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 2.0 |
6.0 |
GO:0060489 |
orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 2.0 |
4.0 |
GO:0072190 |
ureter urothelium development(GO:0072190) |
| 1.9 |
13.0 |
GO:0061312 |
BMP signaling pathway involved in heart development(GO:0061312) |
| 1.8 |
5.5 |
GO:0071898 |
odontoblast differentiation(GO:0071895) regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 1.8 |
5.5 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 1.8 |
5.3 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 1.6 |
9.9 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 1.6 |
4.9 |
GO:0048105 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 1.6 |
6.5 |
GO:1904393 |
regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) |
| 1.6 |
4.8 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 1.6 |
1.6 |
GO:0003134 |
BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) |
| 1.4 |
7.2 |
GO:0010668 |
ectodermal cell differentiation(GO:0010668) |
| 1.4 |
1.4 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 1.4 |
2.8 |
GO:0061144 |
alveolar secondary septum development(GO:0061144) |
| 1.4 |
10.8 |
GO:0044027 |
hypermethylation of CpG island(GO:0044027) |
| 1.3 |
6.7 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 1.3 |
3.9 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 1.3 |
1.3 |
GO:0051450 |
myoblast proliferation(GO:0051450) regulation of myoblast proliferation(GO:2000291) |
| 1.3 |
3.8 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 1.2 |
7.3 |
GO:0003383 |
apical constriction(GO:0003383) |
| 1.2 |
4.8 |
GO:0019323 |
pentose catabolic process(GO:0019323) |
| 1.2 |
5.8 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 1.2 |
5.8 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 1.1 |
1.1 |
GO:0072095 |
regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
| 1.1 |
13.6 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 1.1 |
4.5 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 1.1 |
4.4 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 1.1 |
3.3 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 1.1 |
5.4 |
GO:1904685 |
positive regulation of metalloendopeptidase activity(GO:1904685) |
| 1.1 |
1.1 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 1.1 |
3.2 |
GO:0036363 |
transforming growth factor beta activation(GO:0036363) |
| 1.1 |
3.2 |
GO:0071163 |
DNA replication preinitiation complex assembly(GO:0071163) |
| 1.1 |
3.2 |
GO:0061181 |
regulation of chondrocyte development(GO:0061181) |
| 1.0 |
4.2 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 1.0 |
4.1 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 1.0 |
4.1 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 1.0 |
4.1 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 1.0 |
3.0 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 1.0 |
2.0 |
GO:0048382 |
mesendoderm development(GO:0048382) |
| 1.0 |
4.0 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 1.0 |
1.0 |
GO:2000054 |
negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
| 1.0 |
1.0 |
GO:0033128 |
negative regulation of histone phosphorylation(GO:0033128) |
| 1.0 |
4.0 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 1.0 |
2.9 |
GO:0086053 |
AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 1.0 |
2.9 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 1.0 |
6.8 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) |
| 1.0 |
2.9 |
GO:0060242 |
contact inhibition(GO:0060242) |
| 1.0 |
3.8 |
GO:2001045 |
negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.9 |
5.7 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.9 |
3.7 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 0.9 |
3.7 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.9 |
0.9 |
GO:0033122 |
regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 0.9 |
1.8 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.9 |
1.8 |
GO:0060167 |
regulation of adenosine receptor signaling pathway(GO:0060167) |
| 0.9 |
0.9 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.9 |
2.7 |
GO:0060839 |
endothelial cell fate commitment(GO:0060839) |
| 0.9 |
4.4 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.9 |
0.9 |
GO:0048793 |
pronephros development(GO:0048793) |
| 0.9 |
3.5 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.9 |
1.7 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.9 |
1.7 |
GO:0033278 |
cell proliferation in midbrain(GO:0033278) |
| 0.9 |
0.9 |
GO:0042097 |
interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
| 0.9 |
1.7 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) |
| 0.9 |
3.4 |
GO:0072369 |
regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.9 |
0.9 |
GO:1903960 |
regulation of anion channel activity(GO:0010359) negative regulation of anion channel activity(GO:0010360) regulation of anion transmembrane transport(GO:1903959) negative regulation of anion transmembrane transport(GO:1903960) |
| 0.8 |
1.7 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.8 |
2.5 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.8 |
0.8 |
GO:0003195 |
tricuspid valve formation(GO:0003195) |
| 0.8 |
7.2 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.8 |
2.4 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.8 |
1.6 |
GO:0014916 |
regulation of lung blood pressure(GO:0014916) |
| 0.8 |
3.1 |
GO:1901492 |
positive regulation of lymphangiogenesis(GO:1901492) |
| 0.8 |
3.1 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.8 |
2.3 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.8 |
3.0 |
GO:0072103 |
glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.7 |
0.7 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.7 |
3.7 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.7 |
3.0 |
GO:0031944 |
negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
| 0.7 |
3.6 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.7 |
0.7 |
GO:1904672 |
regulation of somatic stem cell population maintenance(GO:1904672) |
| 0.7 |
0.7 |
GO:0035799 |
ureter maturation(GO:0035799) |
| 0.7 |
3.6 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.7 |
2.1 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 0.7 |
0.7 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.7 |
2.8 |
GO:0014835 |
myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.7 |
3.4 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.7 |
2.1 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.7 |
2.0 |
GO:0030421 |
defecation(GO:0030421) |
| 0.7 |
2.7 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.7 |
2.0 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.7 |
0.7 |
GO:0032471 |
negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 0.7 |
2.0 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.7 |
1.3 |
GO:0010725 |
regulation of primitive erythrocyte differentiation(GO:0010725) |
| 0.7 |
2.0 |
GO:0000973 |
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.6 |
1.9 |
GO:2000256 |
positive regulation of male germ cell proliferation(GO:2000256) |
| 0.6 |
3.2 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.6 |
3.2 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.6 |
1.3 |
GO:0023016 |
signal transduction by trans-phosphorylation(GO:0023016) |
| 0.6 |
1.9 |
GO:0016332 |
establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 0.6 |
2.5 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.6 |
1.3 |
GO:0044837 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.6 |
0.6 |
GO:2000793 |
cell proliferation involved in heart valve development(GO:2000793) |
| 0.6 |
4.4 |
GO:0035701 |
hematopoietic stem cell migration(GO:0035701) |
| 0.6 |
1.2 |
GO:0000077 |
DNA damage checkpoint(GO:0000077) |
| 0.6 |
2.5 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.6 |
4.3 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.6 |
1.8 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.6 |
1.8 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.6 |
3.0 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.6 |
1.8 |
GO:0051145 |
smooth muscle cell differentiation(GO:0051145) |
| 0.6 |
4.2 |
GO:0043922 |
negative regulation by host of viral transcription(GO:0043922) |
| 0.6 |
3.0 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.6 |
3.0 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.6 |
1.8 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.6 |
1.2 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.6 |
1.2 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.6 |
1.2 |
GO:2000974 |
negative regulation of pro-B cell differentiation(GO:2000974) |
| 0.6 |
5.8 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.6 |
2.3 |
GO:0071105 |
response to interleukin-11(GO:0071105) |
| 0.6 |
1.7 |
GO:2000373 |
regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.6 |
2.3 |
GO:0070346 |
positive regulation of fat cell proliferation(GO:0070346) |
| 0.6 |
2.3 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.6 |
5.1 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.6 |
1.7 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.6 |
1.7 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 0.6 |
1.7 |
GO:0045819 |
plasmacytoid dendritic cell activation(GO:0002270) positive regulation of glycogen catabolic process(GO:0045819) |
| 0.6 |
5.1 |
GO:0070874 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.6 |
0.6 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.6 |
1.7 |
GO:1904760 |
myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 0.6 |
3.4 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.6 |
1.7 |
GO:0045658 |
regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.6 |
2.8 |
GO:0060836 |
lymphatic endothelial cell differentiation(GO:0060836) |
| 0.5 |
1.6 |
GO:1900041 |
negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.5 |
1.6 |
GO:0045004 |
DNA replication proofreading(GO:0045004) |
| 0.5 |
1.1 |
GO:0048842 |
positive regulation of axon extension involved in axon guidance(GO:0048842) |
| 0.5 |
2.6 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) |
| 0.5 |
1.1 |
GO:0045409 |
negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 0.5 |
3.2 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.5 |
0.5 |
GO:0033864 |
positive regulation of NAD(P)H oxidase activity(GO:0033864) |
| 0.5 |
2.6 |
GO:0051132 |
NK T cell activation(GO:0051132) |
| 0.5 |
2.6 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.5 |
4.7 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.5 |
1.5 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.5 |
1.5 |
GO:0035878 |
nail development(GO:0035878) |
| 0.5 |
1.5 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.5 |
1.5 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.5 |
2.5 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.5 |
2.0 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.5 |
2.5 |
GO:0003174 |
mitral valve development(GO:0003174) mitral valve morphogenesis(GO:0003183) |
| 0.5 |
1.5 |
GO:0021986 |
epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.5 |
1.5 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.5 |
3.5 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.5 |
3.9 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.5 |
2.9 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.5 |
1.5 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.5 |
2.0 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.5 |
1.4 |
GO:0015938 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 0.5 |
1.4 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.5 |
4.8 |
GO:0002043 |
blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.5 |
1.9 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
| 0.5 |
1.4 |
GO:1902162 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
| 0.5 |
0.5 |
GO:0072194 |
kidney smooth muscle tissue development(GO:0072194) |
| 0.5 |
1.4 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.5 |
1.9 |
GO:1900224 |
positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) positive regulation of mesoderm development(GO:2000382) |
| 0.5 |
2.8 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.5 |
0.9 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.5 |
2.8 |
GO:0003419 |
growth plate cartilage chondrocyte proliferation(GO:0003419) |
| 0.5 |
0.9 |
GO:0002034 |
angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
| 0.5 |
1.8 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.5 |
0.9 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 0.5 |
2.8 |
GO:0072257 |
metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.5 |
5.5 |
GO:0042403 |
thyroid hormone metabolic process(GO:0042403) |
| 0.5 |
1.4 |
GO:0060667 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
| 0.5 |
3.6 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.5 |
0.5 |
GO:2000850 |
negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 0.4 |
1.3 |
GO:1905065 |
positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
| 0.4 |
1.8 |
GO:0032901 |
positive regulation of neurotrophin production(GO:0032901) |
| 0.4 |
1.3 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.4 |
2.2 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.4 |
3.5 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.4 |
6.6 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.4 |
1.3 |
GO:0072382 |
minus-end-directed vesicle transport along microtubule(GO:0072382) |
| 0.4 |
0.9 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.4 |
2.6 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.4 |
1.3 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.4 |
1.3 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.4 |
1.7 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.4 |
6.5 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.4 |
2.2 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.4 |
1.3 |
GO:0090235 |
regulation of metaphase plate congression(GO:0090235) |
| 0.4 |
0.4 |
GO:0042226 |
interleukin-6 biosynthetic process(GO:0042226) regulation of interleukin-6 biosynthetic process(GO:0045408) |
| 0.4 |
0.4 |
GO:0002901 |
mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 0.4 |
1.3 |
GO:2000987 |
positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 0.4 |
1.3 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.4 |
0.4 |
GO:0072204 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.4 |
1.3 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.4 |
1.3 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.4 |
0.8 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.4 |
1.7 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.4 |
1.7 |
GO:1904504 |
regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.4 |
2.1 |
GO:0003223 |
ventricular compact myocardium morphogenesis(GO:0003223) |
| 0.4 |
8.3 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.4 |
0.8 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 0.4 |
4.1 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.4 |
1.6 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
| 0.4 |
1.2 |
GO:0060423 |
foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
| 0.4 |
1.2 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.4 |
0.8 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
| 0.4 |
2.8 |
GO:0007440 |
foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
| 0.4 |
4.4 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.4 |
0.4 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.4 |
0.4 |
GO:0002062 |
chondrocyte differentiation(GO:0002062) |
| 0.4 |
1.6 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.4 |
3.6 |
GO:1903672 |
positive regulation of sprouting angiogenesis(GO:1903672) |
| 0.4 |
1.6 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.4 |
0.4 |
GO:0097237 |
cellular response to toxic substance(GO:0097237) |
| 0.4 |
3.5 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.4 |
0.8 |
GO:2000138 |
positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 0.4 |
2.7 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.4 |
4.7 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.4 |
0.4 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.4 |
0.4 |
GO:0060298 |
positive regulation of sarcomere organization(GO:0060298) |
| 0.4 |
0.4 |
GO:0035089 |
establishment of apical/basal cell polarity(GO:0035089) |
| 0.4 |
2.3 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.4 |
1.5 |
GO:0030859 |
polarized epithelial cell differentiation(GO:0030859) |
| 0.4 |
1.5 |
GO:0045876 |
positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.4 |
1.9 |
GO:0035087 |
siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.4 |
1.1 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 0.4 |
1.1 |
GO:0031660 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
| 0.4 |
1.5 |
GO:0008156 |
negative regulation of DNA replication(GO:0008156) |
| 0.4 |
2.7 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.4 |
0.8 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.4 |
3.4 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.4 |
1.9 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.4 |
0.4 |
GO:0010612 |
regulation of cardiac muscle adaptation(GO:0010612) |
| 0.4 |
1.5 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.4 |
1.1 |
GO:0098974 |
postsynaptic actin cytoskeleton organization(GO:0098974) |
| 0.4 |
1.1 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.4 |
0.7 |
GO:0034137 |
positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
| 0.4 |
0.7 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.4 |
0.4 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.4 |
0.4 |
GO:2000825 |
positive regulation of androgen receptor activity(GO:2000825) |
| 0.4 |
3.3 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.4 |
1.1 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.4 |
1.1 |
GO:1903896 |
positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
| 0.4 |
1.4 |
GO:0048706 |
embryonic skeletal system development(GO:0048706) |
| 0.4 |
0.4 |
GO:0050995 |
negative regulation of lipid catabolic process(GO:0050995) |
| 0.4 |
1.4 |
GO:0002484 |
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 0.4 |
1.4 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.4 |
1.4 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.4 |
1.8 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.4 |
1.8 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.4 |
1.1 |
GO:1903011 |
negative regulation of bone development(GO:1903011) |
| 0.4 |
5.3 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.4 |
0.7 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
| 0.4 |
1.8 |
GO:0021631 |
optic nerve morphogenesis(GO:0021631) |
| 0.3 |
1.0 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 0.3 |
2.1 |
GO:0033567 |
DNA replication, Okazaki fragment processing(GO:0033567) |
| 0.3 |
0.3 |
GO:0010574 |
regulation of vascular endothelial growth factor production(GO:0010574) |
| 0.3 |
1.7 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.3 |
0.3 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.3 |
0.3 |
GO:0060982 |
coronary artery morphogenesis(GO:0060982) |
| 0.3 |
1.4 |
GO:0046125 |
pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.3 |
1.0 |
GO:0003360 |
brainstem development(GO:0003360) |
| 0.3 |
1.7 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.3 |
1.4 |
GO:0051316 |
attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation(GO:0051316) |
| 0.3 |
2.0 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.3 |
0.3 |
GO:1990791 |
dorsal root ganglion development(GO:1990791) |
| 0.3 |
2.3 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.3 |
1.7 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.3 |
1.0 |
GO:1901355 |
response to rapamycin(GO:1901355) |
| 0.3 |
1.0 |
GO:0045575 |
basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
| 0.3 |
2.3 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 0.3 |
1.3 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.3 |
3.3 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.3 |
1.3 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.3 |
0.3 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.3 |
4.0 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.3 |
3.6 |
GO:0006978 |
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
| 0.3 |
6.9 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 0.3 |
1.3 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.3 |
2.0 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) |
| 0.3 |
2.0 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.3 |
2.3 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.3 |
1.0 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.3 |
2.6 |
GO:2000254 |
regulation of male germ cell proliferation(GO:2000254) |
| 0.3 |
3.6 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.3 |
1.0 |
GO:1904479 |
negative regulation of intestinal absorption(GO:1904479) |
| 0.3 |
1.9 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.3 |
1.3 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.3 |
1.6 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.3 |
4.8 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.3 |
1.9 |
GO:0030853 |
negative regulation of granulocyte differentiation(GO:0030853) |
| 0.3 |
0.6 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 0.3 |
2.2 |
GO:1902166 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 0.3 |
1.0 |
GO:1990927 |
calcium ion regulated lysosome exocytosis(GO:1990927) |
| 0.3 |
2.5 |
GO:1990845 |
adaptive thermogenesis(GO:1990845) |
| 0.3 |
1.6 |
GO:0038033 |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.3 |
0.6 |
GO:1904263 |
positive regulation of TORC1 signaling(GO:1904263) |
| 0.3 |
1.6 |
GO:1904721 |
mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 0.3 |
0.6 |
GO:0010838 |
positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.3 |
0.3 |
GO:0043486 |
histone exchange(GO:0043486) |
| 0.3 |
0.9 |
GO:2000659 |
regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.3 |
0.6 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.3 |
1.2 |
GO:1903753 |
negative regulation of p38MAPK cascade(GO:1903753) |
| 0.3 |
0.3 |
GO:0035743 |
CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
| 0.3 |
0.9 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.3 |
1.2 |
GO:0046909 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.3 |
0.9 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 0.3 |
0.9 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
| 0.3 |
0.9 |
GO:0060821 |
inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.3 |
0.3 |
GO:0051252 |
regulation of RNA metabolic process(GO:0051252) |
| 0.3 |
2.4 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.3 |
3.0 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.3 |
0.9 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.3 |
4.5 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.3 |
1.5 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.3 |
0.9 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.3 |
1.2 |
GO:1902953 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.3 |
4.7 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.3 |
0.9 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.3 |
1.2 |
GO:0032055 |
negative regulation of translation in response to stress(GO:0032055) |
| 0.3 |
1.7 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.3 |
1.2 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
| 0.3 |
0.6 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.3 |
0.3 |
GO:1900119 |
regulation of execution phase of apoptosis(GO:1900117) positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.3 |
0.9 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.3 |
0.9 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.3 |
1.4 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.3 |
1.1 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.3 |
2.0 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.3 |
0.6 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.3 |
1.1 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) cellular response to lipid hydroperoxide(GO:0071449) |
| 0.3 |
3.4 |
GO:0030953 |
astral microtubule organization(GO:0030953) |
| 0.3 |
0.8 |
GO:0006578 |
amino-acid betaine biosynthetic process(GO:0006578) |
| 0.3 |
1.7 |
GO:0051383 |
kinetochore organization(GO:0051383) |
| 0.3 |
1.4 |
GO:0000454 |
snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.3 |
1.1 |
GO:0035720 |
intraciliary anterograde transport(GO:0035720) |
| 0.3 |
1.4 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 0.3 |
0.3 |
GO:1904192 |
cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
| 0.3 |
1.7 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.3 |
0.8 |
GO:0006106 |
fumarate metabolic process(GO:0006106) aspartate biosynthetic process(GO:0006532) aspartate catabolic process(GO:0006533) |
| 0.3 |
0.8 |
GO:0072734 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.3 |
2.2 |
GO:0010835 |
regulation of protein ADP-ribosylation(GO:0010835) |
| 0.3 |
2.5 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.3 |
4.1 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 0.3 |
0.3 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 0.3 |
0.5 |
GO:0046121 |
deoxyribonucleoside catabolic process(GO:0046121) |
| 0.3 |
0.3 |
GO:0072498 |
embryonic skeletal joint development(GO:0072498) |
| 0.3 |
0.5 |
GO:0036166 |
phenotypic switching(GO:0036166) |
| 0.3 |
2.2 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
| 0.3 |
1.3 |
GO:0072429 |
response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.3 |
1.3 |
GO:1904948 |
midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.3 |
0.3 |
GO:0045737 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.3 |
2.9 |
GO:1904851 |
positive regulation of establishment of protein localization to telomere(GO:1904851) |
| 0.3 |
0.3 |
GO:0006273 |
lagging strand elongation(GO:0006273) |
| 0.3 |
1.1 |
GO:1903215 |
negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.3 |
0.8 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.3 |
0.8 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.3 |
2.1 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.3 |
8.2 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.3 |
0.5 |
GO:0006409 |
tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.3 |
0.8 |
GO:0060912 |
cardiac cell fate specification(GO:0060912) |
| 0.3 |
0.5 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.3 |
0.5 |
GO:0060455 |
negative regulation of gastric acid secretion(GO:0060455) |
| 0.3 |
1.3 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.3 |
0.8 |
GO:0002295 |
T-helper cell lineage commitment(GO:0002295) |
| 0.3 |
1.0 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.3 |
3.6 |
GO:0035115 |
embryonic forelimb morphogenesis(GO:0035115) |
| 0.3 |
0.3 |
GO:0060066 |
oviduct development(GO:0060066) |
| 0.3 |
1.0 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.3 |
1.0 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.3 |
0.3 |
GO:0032070 |
regulation of deoxyribonuclease activity(GO:0032070) |
| 0.3 |
0.8 |
GO:0043323 |
positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.3 |
3.8 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.3 |
3.6 |
GO:0051895 |
negative regulation of focal adhesion assembly(GO:0051895) |
| 0.3 |
1.8 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.3 |
0.3 |
GO:0045900 |
negative regulation of translational elongation(GO:0045900) |
| 0.3 |
3.8 |
GO:0000578 |
embryonic axis specification(GO:0000578) |
| 0.3 |
2.0 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.3 |
1.5 |
GO:0070827 |
chromatin maintenance(GO:0070827) |
| 0.3 |
1.5 |
GO:0090005 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.3 |
0.5 |
GO:0070103 |
regulation of interleukin-6-mediated signaling pathway(GO:0070103) negative regulation of interleukin-6-mediated signaling pathway(GO:0070104) |
| 0.3 |
1.0 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.3 |
0.8 |
GO:1904569 |
regulation of selenocysteine incorporation(GO:1904569) |
| 0.3 |
1.3 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.3 |
1.3 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.3 |
0.5 |
GO:0097026 |
dendritic cell dendrite assembly(GO:0097026) |
| 0.2 |
0.7 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.2 |
0.7 |
GO:0006547 |
histidine metabolic process(GO:0006547) |
| 0.2 |
0.2 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.2 |
3.0 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.2 |
0.7 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.2 |
0.2 |
GO:0071340 |
skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.2 |
0.5 |
GO:1900186 |
negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.2 |
2.2 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.2 |
0.5 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.2 |
1.0 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 0.2 |
1.2 |
GO:2000645 |
negative regulation of receptor catabolic process(GO:2000645) |
| 0.2 |
0.5 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 0.2 |
1.0 |
GO:0040037 |
negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 0.2 |
1.2 |
GO:0061034 |
olfactory bulb mitral cell layer development(GO:0061034) |
| 0.2 |
1.0 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.2 |
1.0 |
GO:0001550 |
ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.2 |
2.2 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.2 |
1.7 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.2 |
1.9 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.2 |
1.5 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.2 |
2.4 |
GO:0060068 |
vagina development(GO:0060068) |
| 0.2 |
0.5 |
GO:0071707 |
immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
| 0.2 |
0.7 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.2 |
1.7 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.2 |
1.0 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.2 |
1.7 |
GO:0030279 |
negative regulation of ossification(GO:0030279) |
| 0.2 |
7.0 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.2 |
0.2 |
GO:0034140 |
negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
| 0.2 |
1.9 |
GO:0000052 |
citrulline metabolic process(GO:0000052) |
| 0.2 |
0.5 |
GO:0045023 |
G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) negative regulation of G0 to G1 transition(GO:0070317) |
| 0.2 |
0.7 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.2 |
1.0 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.2 |
0.7 |
GO:0003338 |
metanephros morphogenesis(GO:0003338) |
| 0.2 |
0.5 |
GO:1904020 |
regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.2 |
6.8 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.2 |
0.9 |
GO:0002667 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.2 |
5.9 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.2 |
0.5 |
GO:0000448 |
cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
| 0.2 |
1.6 |
GO:0010908 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) |
| 0.2 |
1.9 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.2 |
1.9 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.2 |
2.3 |
GO:0006085 |
acetyl-CoA biosynthetic process(GO:0006085) |
| 0.2 |
0.2 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.2 |
0.7 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.2 |
1.4 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.2 |
0.9 |
GO:0086045 |
membrane depolarization during AV node cell action potential(GO:0086045) |
| 0.2 |
0.9 |
GO:0010288 |
response to lead ion(GO:0010288) |
| 0.2 |
0.9 |
GO:0046719 |
regulation by virus of viral protein levels in host cell(GO:0046719) |
| 0.2 |
1.2 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.2 |
0.7 |
GO:1990859 |
cellular response to endothelin(GO:1990859) |
| 0.2 |
1.1 |
GO:0021592 |
fourth ventricle development(GO:0021592) |
| 0.2 |
0.7 |
GO:0097401 |
synaptic vesicle lumen acidification(GO:0097401) |
| 0.2 |
0.5 |
GO:1902513 |
regulation of organelle transport along microtubule(GO:1902513) |
| 0.2 |
1.1 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 0.2 |
0.9 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.2 |
2.0 |
GO:0090205 |
positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
| 0.2 |
2.3 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.2 |
0.9 |
GO:0051309 |
female meiosis chromosome separation(GO:0051309) |
| 0.2 |
0.4 |
GO:0090261 |
positive regulation of inclusion body assembly(GO:0090261) |
| 0.2 |
0.7 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.2 |
1.1 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 0.2 |
0.4 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.2 |
0.2 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.2 |
0.4 |
GO:0031954 |
positive regulation of protein autophosphorylation(GO:0031954) |
| 0.2 |
0.2 |
GO:0051036 |
regulation of endosome size(GO:0051036) |
| 0.2 |
0.2 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.2 |
0.9 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.2 |
2.2 |
GO:0002183 |
cytoplasmic translational initiation(GO:0002183) |
| 0.2 |
2.4 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 0.2 |
0.4 |
GO:0070365 |
hepatocyte differentiation(GO:0070365) |
| 0.2 |
0.7 |
GO:0072182 |
regulation of nephron tubule epithelial cell differentiation(GO:0072182) |
| 0.2 |
0.9 |
GO:0060161 |
positive regulation of dopamine receptor signaling pathway(GO:0060161) |
| 0.2 |
0.9 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.2 |
0.7 |
GO:0009146 |
purine nucleoside triphosphate catabolic process(GO:0009146) |
| 0.2 |
0.7 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.2 |
0.7 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.2 |
0.7 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.2 |
0.9 |
GO:0006166 |
purine ribonucleoside salvage(GO:0006166) |
| 0.2 |
0.7 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.2 |
2.0 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.2 |
0.2 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.2 |
1.1 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.2 |
1.1 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.2 |
0.2 |
GO:2000738 |
positive regulation of stem cell differentiation(GO:2000738) |
| 0.2 |
0.2 |
GO:0070343 |
white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
| 0.2 |
0.6 |
GO:1901675 |
response to methylglyoxal(GO:0051595) negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.2 |
1.3 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
| 0.2 |
0.6 |
GO:0045414 |
regulation of interleukin-8 biosynthetic process(GO:0045414) |
| 0.2 |
0.2 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.2 |
0.2 |
GO:0030949 |
positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.2 |
0.2 |
GO:0045616 |
regulation of keratinocyte differentiation(GO:0045616) |
| 0.2 |
0.6 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.2 |
1.1 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.2 |
0.4 |
GO:1903998 |
regulation of eating behavior(GO:1903998) |
| 0.2 |
0.6 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.2 |
3.6 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.2 |
0.8 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.2 |
2.1 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.2 |
0.6 |
GO:0042823 |
pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.2 |
0.2 |
GO:1900368 |
regulation of RNA interference(GO:1900368) |
| 0.2 |
2.5 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.2 |
0.4 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.2 |
0.8 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.2 |
0.4 |
GO:0010694 |
positive regulation of alkaline phosphatase activity(GO:0010694) |
| 0.2 |
0.6 |
GO:1903911 |
positive regulation of receptor clustering(GO:1903911) |
| 0.2 |
1.7 |
GO:0060340 |
positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.2 |
1.0 |
GO:0006868 |
glutamine transport(GO:0006868) |
| 0.2 |
0.2 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.2 |
0.2 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.2 |
1.9 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 0.2 |
0.6 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.2 |
0.8 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.2 |
1.0 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.2 |
0.4 |
GO:0040010 |
regulation of growth rate(GO:0040009) positive regulation of growth rate(GO:0040010) |
| 0.2 |
0.4 |
GO:2000416 |
regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
| 0.2 |
0.6 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.2 |
1.6 |
GO:0032075 |
positive regulation of nuclease activity(GO:0032075) |
| 0.2 |
0.4 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.2 |
1.2 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.2 |
0.6 |
GO:0070535 |
histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.2 |
1.4 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.2 |
1.6 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.2 |
0.2 |
GO:0019081 |
viral translation(GO:0019081) |
| 0.2 |
0.2 |
GO:1903898 |
negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.2 |
1.4 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.2 |
0.2 |
GO:0014866 |
skeletal myofibril assembly(GO:0014866) |
| 0.2 |
2.0 |
GO:0006309 |
DNA catabolic process, endonucleolytic(GO:0000737) apoptotic DNA fragmentation(GO:0006309) |
| 0.2 |
0.6 |
GO:0043392 |
negative regulation of DNA binding(GO:0043392) |
| 0.2 |
0.2 |
GO:0030538 |
embryonic genitalia morphogenesis(GO:0030538) embryonic hindgut morphogenesis(GO:0048619) |
| 0.2 |
0.4 |
GO:0030647 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.2 |
0.6 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.2 |
1.2 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.2 |
1.9 |
GO:0043923 |
positive regulation by host of viral transcription(GO:0043923) |
| 0.2 |
0.2 |
GO:1903894 |
IRE1-mediated unfolded protein response(GO:0036498) regulation of IRE1-mediated unfolded protein response(GO:1903894) |
| 0.2 |
3.1 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.2 |
0.6 |
GO:0032415 |
regulation of sodium:proton antiporter activity(GO:0032415) positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.2 |
2.9 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.2 |
1.1 |
GO:0021780 |
oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.2 |
0.2 |
GO:1903750 |
regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
| 0.2 |
2.1 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.2 |
0.6 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 0.2 |
0.6 |
GO:0002725 |
negative regulation of T cell cytokine production(GO:0002725) |
| 0.2 |
1.1 |
GO:0030539 |
male genitalia development(GO:0030539) |
| 0.2 |
1.5 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.2 |
0.8 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.2 |
0.4 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.2 |
0.4 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.2 |
0.6 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.2 |
0.4 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.2 |
0.7 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.2 |
0.6 |
GO:0098706 |
ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.2 |
0.9 |
GO:0060297 |
regulation of sarcomere organization(GO:0060297) |
| 0.2 |
0.7 |
GO:0030812 |
negative regulation of nucleotide catabolic process(GO:0030812) |
| 0.2 |
0.2 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.2 |
0.7 |
GO:0045333 |
cellular respiration(GO:0045333) |
| 0.2 |
0.7 |
GO:1904380 |
endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.2 |
1.3 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.2 |
0.5 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.2 |
0.7 |
GO:0048133 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.2 |
0.2 |
GO:0060290 |
transdifferentiation(GO:0060290) |
| 0.2 |
1.3 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.2 |
1.3 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.2 |
0.5 |
GO:0044313 |
protein K6-linked deubiquitination(GO:0044313) |
| 0.2 |
1.8 |
GO:0033182 |
regulation of histone ubiquitination(GO:0033182) |
| 0.2 |
0.4 |
GO:0006560 |
proline metabolic process(GO:0006560) |
| 0.2 |
1.1 |
GO:0071476 |
hypotonic response(GO:0006971) cellular hypotonic response(GO:0071476) |
| 0.2 |
0.2 |
GO:0002016 |
regulation of blood volume by renin-angiotensin(GO:0002016) |
| 0.2 |
1.4 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.2 |
0.7 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.2 |
3.0 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.2 |
0.5 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.2 |
0.2 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.2 |
0.9 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.2 |
0.5 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.2 |
1.2 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.2 |
1.0 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.2 |
2.7 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.2 |
0.2 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.2 |
0.8 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.2 |
0.8 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.2 |
1.0 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.2 |
1.4 |
GO:1903332 |
regulation of protein folding(GO:1903332) |
| 0.2 |
0.8 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.2 |
0.3 |
GO:0071600 |
otic vesicle morphogenesis(GO:0071600) |
| 0.2 |
0.5 |
GO:0050862 |
positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.2 |
0.3 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 0.2 |
0.3 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.2 |
0.5 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.2 |
1.2 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.2 |
0.2 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 0.2 |
0.8 |
GO:0032332 |
positive regulation of chondrocyte differentiation(GO:0032332) |
| 0.2 |
0.3 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.2 |
1.2 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.2 |
1.7 |
GO:0001682 |
tRNA 5'-leader removal(GO:0001682) |
| 0.2 |
1.0 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.2 |
0.8 |
GO:0061051 |
positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.2 |
0.5 |
GO:0016095 |
polyprenol catabolic process(GO:0016095) |
| 0.2 |
0.5 |
GO:0060391 |
positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.2 |
0.3 |
GO:0000963 |
mitochondrial RNA processing(GO:0000963) |
| 0.2 |
0.2 |
GO:0032532 |
regulation of microvillus length(GO:0032532) |
| 0.2 |
1.3 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.2 |
1.5 |
GO:0006337 |
nucleosome disassembly(GO:0006337) |
| 0.2 |
2.9 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.2 |
0.3 |
GO:0000479 |
endonucleolytic cleavage involved in rRNA processing(GO:0000478) endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
| 0.2 |
3.2 |
GO:0060236 |
regulation of mitotic spindle organization(GO:0060236) |
| 0.2 |
0.5 |
GO:1904046 |
negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.2 |
0.3 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.2 |
1.4 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.2 |
0.5 |
GO:0010814 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.2 |
0.5 |
GO:0030210 |
heparin biosynthetic process(GO:0030210) |
| 0.2 |
0.8 |
GO:0072176 |
nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
| 0.2 |
0.5 |
GO:0016132 |
brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
| 0.2 |
2.7 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.2 |
0.2 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.2 |
0.2 |
GO:0097168 |
mesenchymal stem cell proliferation(GO:0097168) |
| 0.2 |
0.5 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.2 |
0.2 |
GO:0035384 |
thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
| 0.2 |
1.3 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.2 |
0.3 |
GO:0045840 |
positive regulation of mitotic nuclear division(GO:0045840) |
| 0.2 |
1.6 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.2 |
0.5 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.2 |
0.8 |
GO:0036123 |
histone H3-K9 dimethylation(GO:0036123) |
| 0.2 |
0.5 |
GO:0048702 |
embryonic neurocranium morphogenesis(GO:0048702) |
| 0.2 |
0.6 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.2 |
1.6 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.2 |
2.0 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.2 |
0.3 |
GO:0016246 |
RNA interference(GO:0016246) |
| 0.2 |
0.5 |
GO:0048853 |
forebrain morphogenesis(GO:0048853) |
| 0.2 |
0.3 |
GO:0060623 |
regulation of chromosome condensation(GO:0060623) |
| 0.2 |
0.9 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.2 |
0.5 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.2 |
0.9 |
GO:0015909 |
long-chain fatty acid transport(GO:0015909) |
| 0.2 |
0.6 |
GO:2000623 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.2 |
0.3 |
GO:2001160 |
regulation of histone H3-K79 methylation(GO:2001160) |
| 0.2 |
4.1 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.2 |
0.9 |
GO:0042574 |
retinal metabolic process(GO:0042574) |
| 0.2 |
0.8 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.2 |
0.2 |
GO:0048340 |
paraxial mesoderm morphogenesis(GO:0048340) |
| 0.2 |
0.8 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 0.2 |
0.3 |
GO:0002309 |
T cell proliferation involved in immune response(GO:0002309) |
| 0.2 |
0.8 |
GO:0090070 |
positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.2 |
0.5 |
GO:1902031 |
regulation of pentose-phosphate shunt(GO:0043456) regulation of NADP metabolic process(GO:1902031) |
| 0.2 |
1.5 |
GO:0071459 |
protein localization to chromosome, centromeric region(GO:0071459) |
| 0.2 |
0.9 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.1 |
0.6 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.1 |
0.4 |
GO:0000237 |
leptotene(GO:0000237) |
| 0.1 |
0.6 |
GO:0009597 |
detection of virus(GO:0009597) |
| 0.1 |
1.6 |
GO:0060351 |
cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.1 |
0.6 |
GO:0035457 |
cellular response to interferon-alpha(GO:0035457) |
| 0.1 |
0.7 |
GO:0046060 |
dATP metabolic process(GO:0046060) |
| 0.1 |
0.1 |
GO:0008214 |
protein demethylation(GO:0006482) protein dealkylation(GO:0008214) demethylation(GO:0070988) |
| 0.1 |
0.3 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.1 |
0.3 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.1 |
0.6 |
GO:0090267 |
positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.1 |
0.3 |
GO:1990839 |
response to endothelin(GO:1990839) |
| 0.1 |
0.3 |
GO:0033239 |
negative regulation of cellular amine metabolic process(GO:0033239) |
| 0.1 |
0.9 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.1 |
0.6 |
GO:1903288 |
positive regulation of potassium ion import(GO:1903288) |
| 0.1 |
0.7 |
GO:0051571 |
positive regulation of histone H3-K4 methylation(GO:0051571) |
| 0.1 |
0.3 |
GO:0006507 |
GPI anchor release(GO:0006507) |
| 0.1 |
0.7 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.1 |
0.3 |
GO:0060382 |
regulation of DNA strand elongation(GO:0060382) |
| 0.1 |
2.4 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.1 |
1.0 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.1 |
0.9 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.1 |
0.4 |
GO:2000675 |
negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.1 |
0.4 |
GO:0002946 |
tRNA C5-cytosine methylation(GO:0002946) |
| 0.1 |
0.9 |
GO:0046602 |
mitotic centrosome separation(GO:0007100) regulation of mitotic centrosome separation(GO:0046602) |
| 0.1 |
1.3 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.1 |
0.6 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.1 |
0.4 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.1 |
0.8 |
GO:0016446 |
somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.1 |
0.7 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.1 |
0.1 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.1 |
0.7 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.1 |
2.1 |
GO:1902042 |
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.1 |
0.6 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.1 |
0.7 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.1 |
1.0 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 |
0.3 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.1 |
0.4 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 0.1 |
2.5 |
GO:1900087 |
positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.1 |
1.3 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.1 |
0.7 |
GO:0045048 |
protein insertion into ER membrane(GO:0045048) |
| 0.1 |
0.1 |
GO:0042637 |
catagen(GO:0042637) |
| 0.1 |
0.4 |
GO:0061075 |
regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) regulation of neural retina development(GO:0061074) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) regulation of amacrine cell differentiation(GO:1902869) positive regulation of amacrine cell differentiation(GO:1902871) |
| 0.1 |
0.8 |
GO:1902369 |
negative regulation of RNA catabolic process(GO:1902369) |
| 0.1 |
1.5 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.1 |
1.2 |
GO:2000580 |
positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.1 |
0.1 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.1 |
0.1 |
GO:0035547 |
interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) |
| 0.1 |
2.2 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.1 |
1.1 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.1 |
2.0 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 0.1 |
0.3 |
GO:0071211 |
protein targeting to vacuole involved in autophagy(GO:0071211) |
| 0.1 |
0.7 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.1 |
0.7 |
GO:0045830 |
positive regulation of B cell mediated immunity(GO:0002714) positive regulation of immunoglobulin mediated immune response(GO:0002891) positive regulation of isotype switching(GO:0045830) |
| 0.1 |
3.2 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.1 |
0.8 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.1 |
0.3 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 |
0.3 |
GO:0006534 |
cysteine metabolic process(GO:0006534) |
| 0.1 |
2.3 |
GO:0042178 |
xenobiotic catabolic process(GO:0042178) |
| 0.1 |
1.3 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
0.3 |
GO:0021553 |
olfactory nerve development(GO:0021553) |
| 0.1 |
0.1 |
GO:0051531 |
NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
| 0.1 |
0.4 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.1 |
0.5 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.1 |
1.2 |
GO:0006356 |
regulation of transcription from RNA polymerase I promoter(GO:0006356) |
| 0.1 |
0.7 |
GO:1900025 |
negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.1 |
0.9 |
GO:1902230 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.1 |
3.4 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.1 |
0.1 |
GO:0034447 |
very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.1 |
0.3 |
GO:0031118 |
rRNA pseudouridine synthesis(GO:0031118) |
| 0.1 |
0.3 |
GO:0006760 |
folic acid-containing compound metabolic process(GO:0006760) pteridine-containing compound metabolic process(GO:0042558) |
| 0.1 |
0.5 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 |
0.4 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.1 |
0.5 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.1 |
0.3 |
GO:0001911 |
negative regulation of leukocyte mediated cytotoxicity(GO:0001911) negative regulation of cell killing(GO:0031342) |
| 0.1 |
0.3 |
GO:0002063 |
chondrocyte development(GO:0002063) |
| 0.1 |
1.9 |
GO:0003416 |
endochondral bone growth(GO:0003416) |
| 0.1 |
0.1 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.1 |
0.8 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.1 |
0.5 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.1 |
0.4 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.1 |
0.9 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.1 |
0.5 |
GO:0097066 |
response to thyroid hormone(GO:0097066) |
| 0.1 |
0.5 |
GO:0070193 |
synaptonemal complex organization(GO:0070193) |
| 0.1 |
0.5 |
GO:0043328 |
protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.1 |
0.4 |
GO:2000642 |
negative regulation of vacuolar transport(GO:1903336) negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.1 |
0.6 |
GO:0060440 |
trachea formation(GO:0060440) regulation of Golgi inheritance(GO:0090170) |
| 0.1 |
0.9 |
GO:0009162 |
deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.1 |
0.6 |
GO:0019400 |
alditol metabolic process(GO:0019400) |
| 0.1 |
0.1 |
GO:0071902 |
positive regulation of protein serine/threonine kinase activity(GO:0071902) |
| 0.1 |
0.8 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
| 0.1 |
1.6 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.1 |
0.5 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.1 |
0.2 |
GO:1901098 |
positive regulation of autophagosome maturation(GO:1901098) |
| 0.1 |
1.0 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.1 |
0.1 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.1 |
0.2 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.1 |
0.4 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.1 |
0.4 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.1 |
3.4 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.1 |
0.2 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.1 |
0.1 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.1 |
0.6 |
GO:1902261 |
positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 0.1 |
1.5 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.1 |
0.5 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.1 |
0.5 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.1 |
0.4 |
GO:1903912 |
regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
| 0.1 |
1.1 |
GO:0006479 |
protein methylation(GO:0006479) protein alkylation(GO:0008213) |
| 0.1 |
0.4 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.1 |
1.1 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.1 |
0.2 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.1 |
1.1 |
GO:1903077 |
negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
| 0.1 |
0.4 |
GO:0051660 |
establishment of centrosome localization(GO:0051660) |
| 0.1 |
1.2 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 |
0.6 |
GO:0048843 |
negative regulation of axon extension involved in axon guidance(GO:0048843) |
| 0.1 |
0.5 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
0.4 |
GO:0060192 |
negative regulation of lipase activity(GO:0060192) |
| 0.1 |
0.4 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.1 |
0.2 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.1 |
0.3 |
GO:1990046 |
positive regulation of mitochondrial DNA replication(GO:0090297) regulation of cardiolipin metabolic process(GO:1900208) positive regulation of cardiolipin metabolic process(GO:1900210) positive regulation of mitochondrial DNA metabolic process(GO:1901860) stress-induced mitochondrial fusion(GO:1990046) |
| 0.1 |
1.3 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.1 |
0.6 |
GO:0035280 |
miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
| 0.1 |
2.1 |
GO:0048384 |
retinoic acid receptor signaling pathway(GO:0048384) |
| 0.1 |
0.8 |
GO:0050667 |
homocysteine metabolic process(GO:0050667) |
| 0.1 |
0.5 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.1 |
0.1 |
GO:0036260 |
7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.1 |
0.8 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.1 |
2.3 |
GO:0019432 |
triglyceride biosynthetic process(GO:0019432) |
| 0.1 |
0.2 |
GO:0000469 |
cleavage involved in rRNA processing(GO:0000469) |
| 0.1 |
1.9 |
GO:0000470 |
maturation of LSU-rRNA(GO:0000470) |
| 0.1 |
0.1 |
GO:0031125 |
rRNA 3'-end processing(GO:0031125) |
| 0.1 |
4.9 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.1 |
1.7 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.1 |
0.6 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.1 |
0.1 |
GO:0051934 |
positive regulation of synaptic transmission, dopaminergic(GO:0032226) dopamine uptake involved in synaptic transmission(GO:0051583) regulation of dopamine uptake involved in synaptic transmission(GO:0051584) catecholamine uptake involved in synaptic transmission(GO:0051934) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
| 0.1 |
0.3 |
GO:0006011 |
UDP-glucose metabolic process(GO:0006011) |
| 0.1 |
0.3 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.1 |
0.3 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.1 |
0.4 |
GO:0051572 |
negative regulation of histone H3-K4 methylation(GO:0051572) |
| 0.1 |
0.3 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.1 |
1.4 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.1 |
0.4 |
GO:0051790 |
short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.1 |
1.0 |
GO:0010800 |
positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.1 |
0.4 |
GO:0009227 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
| 0.1 |
1.3 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
| 0.1 |
0.3 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.1 |
0.4 |
GO:1903846 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.1 |
0.9 |
GO:0045540 |
regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.1 |
0.2 |
GO:0017185 |
peptidyl-lysine hydroxylation(GO:0017185) |
| 0.1 |
1.1 |
GO:0035646 |
endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.1 |
1.0 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 |
0.1 |
GO:0009204 |
deoxyribonucleoside triphosphate catabolic process(GO:0009204) |
| 0.1 |
1.4 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.1 |
2.8 |
GO:0034724 |
DNA replication-independent nucleosome organization(GO:0034724) |
| 0.1 |
0.3 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.1 |
0.2 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) |
| 0.1 |
0.1 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.1 |
0.2 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.1 |
1.0 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.1 |
2.4 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.1 |
0.8 |
GO:0046512 |
sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.1 |
0.3 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.1 |
0.4 |
GO:0009212 |
dTTP biosynthetic process(GO:0006235) deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 0.1 |
1.6 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.1 |
0.7 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.1 |
0.3 |
GO:0090646 |
mitochondrial tRNA processing(GO:0090646) |
| 0.1 |
2.8 |
GO:0048536 |
spleen development(GO:0048536) |
| 0.1 |
0.3 |
GO:0015817 |
histidine transport(GO:0015817) |
| 0.1 |
0.4 |
GO:0060037 |
pharyngeal system development(GO:0060037) |
| 0.1 |
0.1 |
GO:1901896 |
positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.1 |
1.5 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.1 |
0.3 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 |
0.7 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.1 |
1.6 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.1 |
0.1 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.1 |
0.3 |
GO:1903936 |
response to diamide(GO:0072737) cellular response to diamide(GO:0072738) cellular response to sodium arsenite(GO:1903936) |
| 0.1 |
1.3 |
GO:0001569 |
patterning of blood vessels(GO:0001569) |
| 0.1 |
0.7 |
GO:0071166 |
ribonucleoprotein complex localization(GO:0071166) ribonucleoprotein complex export from nucleus(GO:0071426) |
| 0.1 |
0.2 |
GO:0006296 |
nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.1 |
0.7 |
GO:0035904 |
aorta development(GO:0035904) |
| 0.1 |
0.5 |
GO:1903069 |
regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
| 0.1 |
1.3 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 |
0.2 |
GO:0010455 |
positive regulation of cell fate commitment(GO:0010455) |
| 0.1 |
0.4 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.1 |
0.5 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.1 |
0.2 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.1 |
0.5 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.1 |
0.1 |
GO:0010259 |
multicellular organism aging(GO:0010259) |
| 0.1 |
0.4 |
GO:0080184 |
response to stilbenoid(GO:0035634) response to phenylpropanoid(GO:0080184) |
| 0.1 |
1.3 |
GO:0035567 |
non-canonical Wnt signaling pathway(GO:0035567) |
| 0.1 |
1.1 |
GO:0060261 |
positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.1 |
0.2 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 0.1 |
0.9 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 |
0.5 |
GO:0051461 |
regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.1 |
0.7 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.1 |
2.5 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 |
0.1 |
GO:1905076 |
regulation of interleukin-17 secretion(GO:1905076) |
| 0.1 |
1.2 |
GO:0045217 |
cell-cell junction maintenance(GO:0045217) |
| 0.1 |
0.9 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.1 |
0.2 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 |
0.3 |
GO:0097309 |
cap1 mRNA methylation(GO:0097309) |
| 0.1 |
0.1 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.1 |
0.6 |
GO:0030913 |
paranodal junction assembly(GO:0030913) |
| 0.1 |
0.3 |
GO:0061763 |
multivesicular body-lysosome fusion(GO:0061763) |
| 0.1 |
0.2 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.1 |
0.5 |
GO:0000467 |
exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) tRNA catabolic process(GO:0016078) nuclear polyadenylation-dependent tRNA catabolic process(GO:0071038) |
| 0.1 |
3.5 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.1 |
0.4 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.1 |
0.3 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.1 |
2.4 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.1 |
0.3 |
GO:0061647 |
histone H3-K9 modification(GO:0061647) |
| 0.1 |
0.5 |
GO:0000320 |
re-entry into mitotic cell cycle(GO:0000320) |
| 0.1 |
0.5 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.1 |
0.8 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
| 0.1 |
0.5 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.1 |
0.5 |
GO:0000480 |
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.1 |
0.3 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.1 |
0.1 |
GO:0072235 |
distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
| 0.1 |
0.3 |
GO:0051569 |
regulation of histone H3-K4 methylation(GO:0051569) |
| 0.1 |
2.2 |
GO:0009410 |
response to xenobiotic stimulus(GO:0009410) |
| 0.1 |
1.1 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.1 |
3.9 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.1 |
0.2 |
GO:0042536 |
negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
| 0.1 |
1.1 |
GO:0036296 |
response to increased oxygen levels(GO:0036296) |
| 0.1 |
0.5 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.1 |
1.5 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.3 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.1 |
0.3 |
GO:0008045 |
motor neuron axon guidance(GO:0008045) |
| 0.1 |
0.3 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.1 |
1.0 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.1 |
0.2 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
| 0.1 |
0.3 |
GO:0033145 |
positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
| 0.1 |
0.3 |
GO:0045618 |
positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.1 |
0.1 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.1 |
0.3 |
GO:0001803 |
type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
| 0.1 |
0.9 |
GO:0051352 |
negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.1 |
0.8 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 |
0.3 |
GO:0060575 |
intestinal epithelial cell differentiation(GO:0060575) |
| 0.1 |
0.6 |
GO:0051561 |
positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.1 |
2.1 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.1 |
0.4 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 |
0.1 |
GO:0046077 |
dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) 2'-deoxyribonucleotide biosynthetic process(GO:0009265) dUDP metabolic process(GO:0046077) deoxyribose phosphate biosynthetic process(GO:0046385) |
| 0.1 |
7.0 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.1 |
0.2 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.1 |
0.1 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.1 |
0.2 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.1 |
0.2 |
GO:0006670 |
sphingosine metabolic process(GO:0006670) |
| 0.1 |
3.4 |
GO:0006505 |
GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
| 0.1 |
0.5 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.1 |
0.1 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.1 |
0.4 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 0.1 |
0.1 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) glutamine family amino acid biosynthetic process(GO:0009084) |
| 0.1 |
0.5 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.1 |
0.3 |
GO:0009143 |
nucleoside triphosphate catabolic process(GO:0009143) |
| 0.1 |
2.3 |
GO:0033120 |
positive regulation of RNA splicing(GO:0033120) |
| 0.1 |
0.3 |
GO:0006121 |
mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.1 |
1.4 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 |
0.2 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.1 |
0.2 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.1 |
0.2 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.1 |
2.0 |
GO:0016126 |
sterol biosynthetic process(GO:0016126) |
| 0.1 |
0.5 |
GO:0015842 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.1 |
0.1 |
GO:1904170 |
regulation of bleb assembly(GO:1904170) |
| 0.1 |
0.1 |
GO:0061339 |
establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
| 0.1 |
0.8 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.1 |
0.2 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.1 |
0.3 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.1 |
0.5 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.1 |
0.8 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.1 |
0.2 |
GO:1902608 |
regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
| 0.1 |
0.2 |
GO:0019369 |
arachidonic acid metabolic process(GO:0019369) |
| 0.1 |
0.2 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.1 |
0.1 |
GO:0072395 |
signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
| 0.1 |
0.3 |
GO:0046697 |
decidualization(GO:0046697) maternal process involved in female pregnancy(GO:0060135) |
| 0.1 |
0.1 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.1 |
0.4 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.1 |
0.4 |
GO:2000179 |
positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.1 |
1.0 |
GO:0010664 |
negative regulation of striated muscle cell apoptotic process(GO:0010664) |
| 0.1 |
0.2 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.1 |
0.3 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
0.7 |
GO:0032967 |
positive regulation of collagen biosynthetic process(GO:0032967) |
| 0.1 |
0.6 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.1 |
2.4 |
GO:0006289 |
nucleotide-excision repair(GO:0006289) |
| 0.1 |
0.1 |
GO:0007398 |
ectoderm development(GO:0007398) |
| 0.1 |
0.1 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.1 |
0.4 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.1 |
0.3 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.1 |
0.1 |
GO:0050858 |
negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
| 0.1 |
0.2 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.1 |
0.6 |
GO:0006084 |
acetyl-CoA metabolic process(GO:0006084) |
| 0.1 |
0.3 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.1 |
0.5 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) |
| 0.1 |
0.1 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.1 |
0.5 |
GO:0090031 |
positive regulation of steroid hormone biosynthetic process(GO:0090031) |
| 0.1 |
0.1 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.1 |
0.3 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.1 |
0.1 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 0.1 |
0.2 |
GO:0034122 |
negative regulation of toll-like receptor signaling pathway(GO:0034122) |
| 0.1 |
0.1 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.1 |
0.2 |
GO:0002014 |
vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 0.1 |
0.2 |
GO:0034035 |
sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.1 |
0.2 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) L-ascorbic acid metabolic process(GO:0019852) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.1 |
0.9 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.1 |
0.3 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.1 |
1.1 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
0.9 |
GO:1904355 |
positive regulation of telomere capping(GO:1904355) |
| 0.1 |
0.6 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.1 |
0.3 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.1 |
0.3 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.1 |
1.6 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.1 |
0.3 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 |
0.6 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.1 |
0.9 |
GO:0030497 |
fatty acid elongation(GO:0030497) |
| 0.1 |
4.0 |
GO:0006073 |
glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
| 0.1 |
0.1 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.1 |
0.1 |
GO:0051683 |
establishment of Golgi localization(GO:0051683) |
| 0.1 |
0.2 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.1 |
0.1 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.1 |
0.3 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.1 |
0.4 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.1 |
0.4 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
| 0.1 |
0.1 |
GO:0033262 |
regulation of nuclear cell cycle DNA replication(GO:0033262) |
| 0.1 |
0.7 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
0.3 |
GO:0031065 |
positive regulation of histone deacetylation(GO:0031065) |
| 0.1 |
1.1 |
GO:1902850 |
mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
| 0.1 |
0.4 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.1 |
0.8 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.1 |
0.3 |
GO:0032026 |
response to magnesium ion(GO:0032026) |
| 0.1 |
0.4 |
GO:0006541 |
glutamine metabolic process(GO:0006541) |
| 0.1 |
0.1 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.1 |
0.8 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
| 0.1 |
0.4 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.1 |
0.1 |
GO:2000192 |
negative regulation of fatty acid transport(GO:2000192) |
| 0.1 |
0.1 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.1 |
0.3 |
GO:0006616 |
SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.1 |
0.5 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.1 |
0.1 |
GO:0043457 |
regulation of cellular respiration(GO:0043457) |
| 0.1 |
0.2 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 |
0.7 |
GO:0046718 |
viral entry into host cell(GO:0046718) |
| 0.1 |
1.0 |
GO:1903427 |
negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
| 0.1 |
0.2 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.1 |
0.2 |
GO:0098886 |
modification of dendritic spine(GO:0098886) |
| 0.1 |
0.1 |
GO:0031958 |
corticosteroid receptor signaling pathway(GO:0031958) |
| 0.1 |
0.2 |
GO:0050716 |
regulation of interleukin-1 secretion(GO:0050704) positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
| 0.1 |
0.1 |
GO:0042474 |
middle ear morphogenesis(GO:0042474) |
| 0.1 |
0.8 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.1 |
0.2 |
GO:0002903 |
negative regulation of B cell apoptotic process(GO:0002903) |
| 0.1 |
0.6 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
| 0.1 |
0.4 |
GO:0046034 |
ATP metabolic process(GO:0046034) |
| 0.1 |
0.1 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.1 |
0.7 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.1 |
0.1 |
GO:0002101 |
tRNA wobble cytosine modification(GO:0002101) |
| 0.1 |
1.1 |
GO:0006879 |
cellular iron ion homeostasis(GO:0006879) |
| 0.1 |
0.3 |
GO:0006851 |
mitochondrial calcium ion transport(GO:0006851) |
| 0.1 |
1.6 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.1 |
0.1 |
GO:0009994 |
oocyte differentiation(GO:0009994) |
| 0.1 |
0.1 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 |
0.7 |
GO:0000132 |
establishment of mitotic spindle orientation(GO:0000132) |
| 0.1 |
0.1 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.1 |
0.2 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.1 |
0.8 |
GO:0010862 |
positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.1 |
0.6 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.1 |
0.3 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
0.2 |
GO:0016458 |
gene silencing(GO:0016458) gene silencing by RNA(GO:0031047) |
| 0.1 |
0.1 |
GO:1903294 |
glutamate secretion, neurotransmission(GO:0061535) regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
| 0.1 |
0.4 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.1 |
0.8 |
GO:0035411 |
catenin import into nucleus(GO:0035411) |
| 0.1 |
1.1 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.1 |
1.2 |
GO:0007566 |
embryo implantation(GO:0007566) |
| 0.1 |
0.3 |
GO:0051150 |
regulation of smooth muscle cell differentiation(GO:0051150) |
| 0.1 |
0.2 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.1 |
0.1 |
GO:2000823 |
regulation of androgen receptor activity(GO:2000823) |
| 0.1 |
0.3 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.1 |
0.6 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.1 |
0.2 |
GO:0044829 |
modulation by host of viral genome replication(GO:0044827) positive regulation by host of viral genome replication(GO:0044829) |
| 0.1 |
0.3 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.1 |
0.2 |
GO:0070849 |
response to epidermal growth factor(GO:0070849) |
| 0.1 |
0.2 |
GO:0048010 |
vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
| 0.0 |
0.1 |
GO:1903504 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.0 |
2.7 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.0 |
0.2 |
GO:0072530 |
purine-containing compound transmembrane transport(GO:0072530) |
| 0.0 |
0.6 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.0 |
0.2 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.0 |
0.3 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.0 |
0.1 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
| 0.0 |
0.2 |
GO:2000191 |
regulation of fatty acid transport(GO:2000191) |
| 0.0 |
0.1 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.0 |
0.1 |
GO:0045657 |
positive regulation of monocyte differentiation(GO:0045657) |
| 0.0 |
0.2 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.0 |
0.0 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.0 |
0.2 |
GO:0048147 |
negative regulation of fibroblast proliferation(GO:0048147) |
| 0.0 |
0.3 |
GO:0090201 |
negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.0 |
0.5 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.0 |
0.7 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.0 |
2.3 |
GO:0031497 |
chromatin assembly(GO:0031497) |
| 0.0 |
0.6 |
GO:0046856 |
phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 |
0.3 |
GO:0098909 |
regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
| 0.0 |
0.2 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.0 |
0.6 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.0 |
0.2 |
GO:0070059 |
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
| 0.0 |
0.3 |
GO:0033687 |
osteoblast proliferation(GO:0033687) |
| 0.0 |
0.1 |
GO:0046477 |
glycosylceramide catabolic process(GO:0046477) |
| 0.0 |
0.9 |
GO:2001244 |
positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
| 0.0 |
1.2 |
GO:0032608 |
interferon-beta production(GO:0032608) |
| 0.0 |
0.2 |
GO:0036035 |
osteoclast development(GO:0036035) |
| 0.0 |
0.4 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.0 |
0.1 |
GO:0018195 |
peptidyl-arginine modification(GO:0018195) |
| 0.0 |
3.8 |
GO:0030308 |
negative regulation of cell growth(GO:0030308) |
| 0.0 |
0.2 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.0 |
0.1 |
GO:0044819 |
mitotic G1/S transition checkpoint(GO:0044819) |
| 0.0 |
0.4 |
GO:0034219 |
carbohydrate transmembrane transport(GO:0034219) |
| 0.0 |
0.7 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.0 |
0.1 |
GO:0046950 |
cellular ketone body metabolic process(GO:0046950) |
| 0.0 |
0.1 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.0 |
0.2 |
GO:0030811 |
regulation of glycolytic process(GO:0006110) regulation of nucleotide catabolic process(GO:0030811) |
| 0.0 |
0.3 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 |
0.4 |
GO:0001937 |
negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.0 |
0.1 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.0 |
0.3 |
GO:0009048 |
dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.0 |
0.1 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.0 |
1.5 |
GO:0001841 |
neural tube formation(GO:0001841) |
| 0.0 |
0.1 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.0 |
0.0 |
GO:0002092 |
positive regulation of receptor internalization(GO:0002092) |
| 0.0 |
0.1 |
GO:0032506 |
cytokinetic process(GO:0032506) |
| 0.0 |
0.3 |
GO:2000398 |
regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.0 |
0.1 |
GO:0048820 |
hair follicle maturation(GO:0048820) |
| 0.0 |
0.1 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 0.0 |
0.2 |
GO:0033034 |
positive regulation of neutrophil apoptotic process(GO:0033031) positive regulation of myeloid cell apoptotic process(GO:0033034) |
| 0.0 |
1.8 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 |
0.1 |
GO:0045912 |
negative regulation of carbohydrate metabolic process(GO:0045912) |
| 0.0 |
0.1 |
GO:1903756 |
regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.0 |
0.5 |
GO:0046033 |
AMP metabolic process(GO:0046033) |
| 0.0 |
0.1 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 0.0 |
0.1 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.0 |
0.0 |
GO:0051769 |
nitric-oxide synthase biosynthetic process(GO:0051767) regulation of nitric-oxide synthase biosynthetic process(GO:0051769) positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.0 |
0.3 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.0 |
0.3 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.0 |
0.1 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.0 |
0.1 |
GO:2000643 |
positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.0 |
0.2 |
GO:0046643 |
regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.0 |
0.1 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 |
0.0 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.0 |
0.2 |
GO:1902751 |
positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.0 |
0.3 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.0 |
0.1 |
GO:0019885 |
antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.0 |
0.1 |
GO:0006921 |
cellular component disassembly involved in execution phase of apoptosis(GO:0006921) |
| 0.0 |
0.7 |
GO:0006821 |
chloride transport(GO:0006821) |
| 0.0 |
0.1 |
GO:0031034 |
myosin filament assembly(GO:0031034) |
| 0.0 |
0.7 |
GO:0050830 |
defense response to Gram-positive bacterium(GO:0050830) |
| 0.0 |
0.5 |
GO:0038202 |
TORC1 signaling(GO:0038202) |
| 0.0 |
0.1 |
GO:0033363 |
acrosome assembly(GO:0001675) secretory granule organization(GO:0033363) |
| 0.0 |
0.1 |
GO:0044003 |
modification by symbiont of host morphology or physiology(GO:0044003) |
| 0.0 |
0.1 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.0 |
GO:0080144 |
amino acid homeostasis(GO:0080144) |
| 0.0 |
0.2 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.0 |
0.0 |
GO:0006405 |
RNA export from nucleus(GO:0006405) |
| 0.0 |
0.1 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.0 |
0.0 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.0 |
0.1 |
GO:1902065 |
response to L-glutamate(GO:1902065) |
| 0.0 |
0.0 |
GO:0070601 |
centromeric sister chromatid cohesion(GO:0070601) |
| 0.0 |
0.1 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.0 |
0.1 |
GO:1902525 |
regulation of protein monoubiquitination(GO:1902525) |
| 0.0 |
0.0 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.0 |
0.5 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.0 |
0.1 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.0 |
0.1 |
GO:1904738 |
vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
| 0.0 |
0.2 |
GO:0030473 |
nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
| 0.0 |
0.1 |
GO:0021794 |
thalamus development(GO:0021794) |
| 0.0 |
0.2 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.0 |
0.1 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 0.0 |
0.4 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.0 |
0.0 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.0 |
0.2 |
GO:0019731 |
antimicrobial humoral response(GO:0019730) antibacterial humoral response(GO:0019731) |
| 0.0 |
0.1 |
GO:0019083 |
viral transcription(GO:0019083) |
| 0.0 |
0.2 |
GO:1900181 |
negative regulation of protein localization to nucleus(GO:1900181) |
| 0.0 |
0.1 |
GO:0014823 |
response to activity(GO:0014823) |
| 0.0 |
0.2 |
GO:0055070 |
copper ion homeostasis(GO:0055070) |
| 0.0 |
0.1 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.0 |
0.2 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 |
0.2 |
GO:0032785 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.0 |
0.1 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.0 |
0.2 |
GO:1901071 |
N-acetylglucosamine metabolic process(GO:0006044) glucosamine-containing compound metabolic process(GO:1901071) |
| 0.0 |
0.4 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.0 |
0.1 |
GO:1904293 |
negative regulation of ERAD pathway(GO:1904293) |
| 0.0 |
0.1 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 |
0.1 |
GO:0045646 |
regulation of erythrocyte differentiation(GO:0045646) |
| 0.0 |
0.0 |
GO:0006244 |
pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.0 |
0.1 |
GO:1903321 |
negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
| 0.0 |
0.1 |
GO:0060586 |
multicellular organismal iron ion homeostasis(GO:0060586) |
| 0.0 |
0.2 |
GO:0045724 |
positive regulation of cilium assembly(GO:0045724) |
| 0.0 |
0.1 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 0.0 |
0.0 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.0 |
0.0 |
GO:2000036 |
regulation of stem cell population maintenance(GO:2000036) |
| 0.0 |
0.5 |
GO:0071526 |
semaphorin-plexin signaling pathway(GO:0071526) |
| 0.0 |
0.1 |
GO:1904469 |
positive regulation of tumor necrosis factor secretion(GO:1904469) |
| 0.0 |
0.2 |
GO:0090199 |
regulation of release of cytochrome c from mitochondria(GO:0090199) |
| 0.0 |
1.4 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.0 |
0.1 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.0 |
0.1 |
GO:1902047 |
polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.0 |
0.2 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.0 |
0.1 |
GO:0070162 |
adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
| 0.0 |
0.0 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.0 |
0.2 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.0 |
0.3 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 |
0.1 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.0 |
0.1 |
GO:1900744 |
regulation of p38MAPK cascade(GO:1900744) |
| 0.0 |
0.4 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.0 |
0.3 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.0 |
0.1 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.0 |
0.0 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.0 |
0.2 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.0 |
0.1 |
GO:2001044 |
regulation of integrin-mediated signaling pathway(GO:2001044) |
| 0.0 |
0.1 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.0 |
0.1 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) myelin maintenance(GO:0043217) |
| 0.0 |
0.0 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.0 |
0.0 |
GO:2000811 |
negative regulation of anoikis(GO:2000811) |
| 0.0 |
0.1 |
GO:0050820 |
positive regulation of coagulation(GO:0050820) |
| 0.0 |
0.1 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.0 |
0.2 |
GO:0018342 |
protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.0 |
0.4 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.0 |
0.1 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.0 |
0.1 |
GO:0048753 |
pigment granule organization(GO:0048753) |
| 0.0 |
0.2 |
GO:0015858 |
nucleoside transport(GO:0015858) |
| 0.0 |
0.0 |
GO:0030520 |
intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.0 |
0.0 |
GO:0021852 |
pyramidal neuron migration(GO:0021852) |
| 0.0 |
0.1 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.0 |
0.2 |
GO:0072337 |
modified amino acid transport(GO:0072337) |
| 0.0 |
0.0 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.0 |
0.0 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.0 |
0.0 |
GO:0035928 |
RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
| 0.0 |
1.3 |
GO:0042254 |
ribosome biogenesis(GO:0042254) |
| 0.0 |
0.0 |
GO:0032695 |
negative regulation of interleukin-12 production(GO:0032695) |
| 0.0 |
0.0 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 0.0 |
0.1 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.0 |
0.8 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.0 |
0.1 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.0 |
0.0 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.0 |
0.1 |
GO:0003170 |
heart valve development(GO:0003170) |
| 0.0 |
0.1 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.0 |
0.0 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.0 |
0.1 |
GO:0030157 |
pancreatic juice secretion(GO:0030157) |
| 0.0 |
0.1 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.0 |
0.1 |
GO:0001658 |
branching involved in ureteric bud morphogenesis(GO:0001658) |
| 0.0 |
0.0 |
GO:0006767 |
water-soluble vitamin metabolic process(GO:0006767) |
| 0.0 |
0.4 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.0 |
0.0 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.0 |
0.1 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
| 0.0 |
0.1 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.0 |
0.0 |
GO:0060268 |
negative regulation of respiratory burst(GO:0060268) |
| 0.0 |
0.1 |
GO:0051353 |
positive regulation of oxidoreductase activity(GO:0051353) |
